Patent Information
- (54) Name
- Combination of HMG-CoA reductase inhibitors atorvastatin or simvastatin with a phosphodiesterase 4 inhibitor, such as roflumilast for the treatment of inflammatory pulmonary diseases
- (21) Filing number
- PT31825
- (21) EP Number
- 2363130 (open in ep register)
- (51) Classification
- N/A
- Supplementary Protection
- N/A
- (22) Application date
- 03/07/2014
- (24) Registration date
- 07/10/2017
- Expiry date
- 03/07/2020 Renew
- Status
- Lapsed
- Protection period
- 13
Priority Details
N/A
Applicant Details
| (731) Name / Company | Address | State | Town | Post code | Country |
|---|---|---|---|---|---|
| AstraZeneca AB | Södertälje | 151 85 | Sweden |
Inventor Details
N/A
Representative Details
| (731) Name / Company | Address | State | Town | Post code | Country |
|---|---|---|---|---|---|
| Dr. Luigi A. Sansone | SALOMONE SANSONE 84-85, Melita Street | Valletta | VLT 1120 | Malta |
All Documents
N/A